TGFB1 and neoplasm: TGF-β1 contributes to the malignant TME through the recruitment and induction of immune-suppressive myeloid and regulatory T cells, each known to dynamically suppress the function of tumor-reactive cytotoxic T cells and natural killer (NK) cells (10, 11).